Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Journal Volume
121
Journal Issue
8
Pages
1579-1587
Date Issued
2022-08
Author(s)
Abstract
Prothrombin Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) is a diagnostic marker for hepatocellular carcinoma (HCC). Transarterial chemoembolization (TACE) is the standard management for intermediate stage HCC but lacks effective response predictors. We investigated the utility of PIVKA-II as a predictor of TACE response.
Subjects
Des-gamma carboxyprothrombin; Liver cancer; PIVKA-II; Prothrombin induced by vitamin K absence or antagonist-I; TACE
SDGs
Publisher
ELSEVIER TAIWAN
Type
journal article